(MedPage Today) — Adding precision immunotherapy targeting macrophage activation-like syndrome and sepsis-induced immunoparalysis to standard care improved organ dysfunction by day 9 compared with standard care plus placebo, the phase IIb randomized…
Source link : https://www.medpagetoday.com/criticalcare/sepsis/118898
Author :
Publish date : 2025-12-08 22:45:00
Copyright for syndicated content belongs to the linked Source.
